Free readiness scan for Journal of Clinical Oncology.
THE clinical cancer journal: where trials that change treatment guidelines get published and practice is transformed
Upload your manuscript and see the first desk-rejection risks, journal-fit verdict, and top reviewer objections calibrated for Journal of Clinical Oncology in about 1-2 minutes.
Impact factor
41.9
Acceptance
~15%
First decision
~30 days
Anthropic Privacy Partner
Zero-retention manuscript processing. Your manuscript is not used for training.
Start free preview
Get a fast submission-risk check
Used by 5,000+ researchers. Readiness, desk-screen risk, and the top blockers in about 90 seconds.
Free manuscript scan · Full report from $39
What Journal of Clinical Oncology editors screen for
The signals Journal of Clinical Oncology rewards before the first reviewer
The readiness scan checks your manuscript against these first.
Practice-changing clinical evidence
JCO exists to change how cancer is treated. Your study should answer a question that oncologists face in clinic every day. If treatment guidelines won't be updated based on your findings, JCO probably isn't the right venue.
Definitive answers, not promising signals
Phase 3 trials with clear primary endpoints, adequate power, and clinically meaningful differences. JCO doesn't publish 'encouraging trends' or 'signals of activity.' They publish evidence that settles clinical questions.
Patient-centered outcomes that matter
Overall survival, progression-free survival, quality of life: outcomes that patients and oncologists actually care about. Surrogate endpoints need strong validation or exceptional circumstances.
Common Journal of Clinical Oncology rejection patterns
Named failure modes the scan looks for
These are patterns Journal of Clinical Oncology editors flag in initial triage. The free preview surfaces when your manuscript shows them.
Submitting Phase 2 trials without exceptional justification
JCO wants definitive evidence. Phase 2 trials need to be in rare cancers, novel mechanisms, or situations where Phase 3 isn't feasible. Most Phase 2 data belongs in specialty oncology journals.
Post-hoc analyses masquerading as primary endpoints
JCO editors scrutinize trial registration and protocol amendments. Any deviation from the original statistical plan must be clearly labeled and justified. Gaming the system gets caught.
Ignoring quality of life and patient-reported outcomes
A treatment that extends survival by 2 months but destroys quality of life isn't a clear win. JCO increasingly values patient-reported outcomes alongside traditional endpoints.
Common questions about Journal of Clinical Oncology submissions
Does the scan understand Journal of Clinical Oncology's editorial standards?
The readiness scan is calibrated to Journal of Clinical Oncology's scope and review signals. It estimates desk-rejection risk against known triage patterns, flags where your manuscript sits against journal fit, and surfaces the specific reviewer objections most likely to come up.
How long does the Journal of Clinical Oncology scan take?
The free preview takes about 1-2 minutes once you upload. If you want the Full Review with verified citations and section-by-section critique, it is delivered as a DOCX in about 30 minutes, after hundreds of parallel frontier-model LLM calls per review.
Is my manuscript safe?
Yes. Uploads are encrypted in transit, not used to train any AI model, and deleted after analysis. No human reads your manuscript on the AI path.
Where can I read more about Journal of Clinical Oncology?
See the full Journal of Clinical Oncology submission guide for scope details, insider tips, and acceptance-rate context. Or see how the Full Review works across all journals.
Find out before Journal of Clinical Oncology's editors do
Your reviewers will find these issues. The question is whether you find them first. Free preview in 1-2 minutes.
Start the free Journal of Clinical Oncology scan